Chronic Plaque Psoriasis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Chronic plaque psoriasis, also known as psoriasis vulgaris, represents a persistent inflammatory dermatological condition characterized by well-defined, erythematous, and scaly plaques predominantly affecting the body's and scalp's extensor surfaces. These lesions may intermittently elicit pruritus or a stinging sensation and can exhibit bleeding upon trauma. Dystrophic nail alterations, including nail pitting, are observed in over a third of individuals with chronic plaque psoriasis, while psoriatic arthropathy manifests in 1% to over 10% of cases. The disease course of chronic plaque psoriasis is marked by periods of exacerbation and remission, exhibiting substantial inter-individual variability in severity and progression. Additional subtypes of psoriasis include guttate, inverse, pustular, and erythrodermic presentations. While approximately one-third of individuals affected by psoriasis have a familial predisposition to the disease, external factors such as physical trauma, acute infections, and certain medications (e.g., lithium and beta-blockers) are implicated in triggering disease onset. Observational evidence suggests associations between psoriasis and stressful life events, cigarette smoking, and, to a lesser extent, alcohol consumption. Additionally, correlations have been reported between psoriasis and factors such as body mass index (BMI) and dietary patterns low in fruits and vegetables. Diagnosis of psoriasis relies primarily on the clinical presentation of cutaneous lesions. However, a biopsy may be warranted to differentiate psoriasis from similar-appearing conditions such as lichen simplex chronicus, nummular eczema, seborrheic dermatitis, and tinea corporis. While chronic plaque psoriasis generally does not impact life expectancy, it can be complicated by various comorbidities, including malignancies, arthritis, and emotional distress stemming from its cosmetic repercussions. Concomitant psychological manifestations such as depression, anxiety, sexual dysfunction, low self-esteem, and suicidal ideation may co-occur with psoriasis, even in cases of milder disease severity. Topical therapies form the cornerstone of psoriasis management and encompass a range of agents, including steroids, vitamin D derivatives, retinoids, immunosuppressants, anthralin, coal tar ointment, and various other modalities.
Thelansis’s “Chronic Plaque Psoriasis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Chronic Plaque Psoriasis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Chronic Plaque Psoriasis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Chronic Plaque Psoriasis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment